7:05 PM
 | 
Sep 23, 2014
 |  BC Extra  |  Financial News

Eureka raises $21M in C round

Cancer company Eureka Therapeutics Inc. (Emeryville, Calif.) raised $21 million in an untranched series C round led by new investor...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >